IP Library Granted Patent US 7,229,811
Granted Patent B2
US 7,229,811 · App. 10/343,369 · Granted Jun 12, 2007

2,5-diketo-D-gluconic acid (2,5-DKG) permeases

Assignees: Genencor International, Inc.; E.P.I. Liquidation Co.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,229,811
App. No.
10/343,369
Granted
Jun 12, 2007
Kind
B2
Abstract

The invention provides isolated nucleic acid molecules encoding polypeptides having 2,5-DKG permease activity, and oligonucleotides therefrom. The isolated nucleic acid molecules can be expressed in appropriate bacterial cells to enhance the production of 2-KLG, which can subsequently be converted to ascorbic acid. Further provided are isolated polypeptides having 2,5-DKG permease acitivity, immunogenic peptides therefrom, and antibodies specific therefor. The invention also provides methods of identifying novel 2,5-DKG permeases.

Claims (21)

1. An isolated nucleic acid molecule comprising a nucleotide sequence which encodes a polypeptide having at least 95% identity to the amino acid sequence of SEQ ID NO:4, wherein said polypeptide has 2,5-diketo-gluconate (2,5-DKG) permease activity.

2. The isolated nucleic acid molecule of claim 1 which encodes a polypeptide having the amino acid sequence of SEQ ID NO:4.

3. The isolated nucleic acid molecule of claim 1 operatively linked to a promoter of gene expression.

4. The isolated nucleic acid molecule of claim 3 , wherein said promoter is a lac promoter.

5. A vector comprising the isolated nucleic acid molecule of claim 3 .

6. A bacterial cell comprising the vector of claim 5 .

7. The bacterial cell of claim 6 , wherein said isolated nucleic acid molecule comprises a nucleotide sequence which encodes a polypeptide having an amino acid sequence at least 98% identical to the amino acid sequence of SEQ ID NO:4.

8. The bacterial cell of claim 6 , which is of the genus Kiebsiella.

9. The bacterial cell of claim 6 , which is of the genus Pantoea.

10. The bacterial cell of claim 6 , which expresses an enzyme that catalyzes the conversion of 2.5-DKG to 2-keto-L-gulonic acid (2-KLG).

11. The bacterial cell of claim 10 , which expresses enzymes that catalyze the conversion of glucose to 2,5-DKG.

12. A method of enhancing 2-keto-L-gulonic acid (2-KLG) production, comprising a) introducing the isolated nucleic acid molecule of claim 1 into a bacterial cell which expresses an enzyme that catalyzes the conversion of 2,5-DKG to 2-KLG, b) allowing expression of the polypeptide encoded by said nucleic acid molecule end c) culturing the bacterial cell under suitable conditions to produce 2-KLG.

13. The method of claim 12 , wherein said bacterial cell further expresses enzymes that catalyze the conversion of glucose to 2,5-DKG.

14. The method of claim 12 , wherein said bacterial cell is of the genus Pantoea.

15. The method of claim 12 , further comprising converting said 2-KLG to ascorbic acid.

16. The bacterial cell of claim 6 , which is an E. coil cell.

17. The method of claim 12 , wherein the nucleic add molecule encodes a polypeptide having the sequence of SEQ ID NO: 4.

18. The method of claim 12 , wherein the nucleic acid molecule has the sequence of SEQ ID NO: 3 or a sequence having at least 95% sequence identity thereto.

19. The isolated nucleic acid of claim 1 which encodes a polypeptide having at least 98% sequence identity to SEQ ID NO: 4.

20. The method according to claim 12 , wherein the nucleic acid molecule encodes a polypeptide having at least 98% sequence identity to SEQ ID NO: 4.

21. The vector of claim 5 , comprising a spectinomycin resistance gene.

Assignments (2)
CHANGE OF NAME Recorded Jun 30, 2010
From: GENENCOR INTERNATIONAL, INC.
To: DANISCO US INC.
Reel/Frame 024619/0304 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2003
From: KUMAR, MANOJ; VALLE, FERNANDO; DARTOIS, VERONIQUE; HOCH, JAMES A.
To: GENENCOR INTERNATIONAL, INC.; MICROGENOMICS, INC.
Reel/Frame 013863/0885 →
Continuity (1)
Related Publication 20040030113A1 · Feb 12, 2004